Departmental Publications


2012 Publications


AUTOPSY

  1. Burton EC, Mossa-Basha M. To image or to autopsy? Ann Intern Med 2012 Jan17;156(2)158-9.
  2. Gibbs WN, Opatowsky MJ, Burton EC. AIRP best cases in radiologic-pathologic correlation: cerebral fat embolism syndrome in sickle cell β-thalassemia. Radiographics. 2012 Sep-Oct;32(5):1301-6.

CARDIOVASCULAR PATHOLOGY

  1. Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E, Steenbergen C. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res. 2012 Jun 8;110(12):1596-603.
  2. Das S, Steenbergen C. Mitochondrial adenine nucleotide transport and cardioprotection. J Mol Cell Cardiol. 2012 Feb;52(2):448-53.
  3. Halushka MK. Single gene disorders of the aortic wall. Cardiovasc Pathol 2012 Jul;21(4):240-4.
  4. Holmes BJ, Delev NG, Pasternack GR, Halushka MK. Novel cause of sudden cardiac death: IgG4-related disease. Circulation 2012 Jun;125(23):2956-7.
  5. Kohr MJ, Aponte A, Sun J, Gucek M, Steenbergen C, Murphy E. Measurement of s-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication. Circ Res. 2012 Oct 26;111(10):1308-12.
  6. Kohr MJ, Roof SR, Zweir JL, Ziolo MT. Modulation of myocardial contraction by peroxynitrite. Front Physiol 2012 Dec;3:468
  7. Liu CY, Liu YC, Venkatesh BA, Lima JA, Bluemke DA, Steenbergen C. Heterogeneous distribution of myocardial steatosis-An ex vivo evaluation. Magn Reson Med 2012 Jul;68(1):1-7.
  8. Murphy E, Kohr M, Sun J, Nguyen T, Steenbergen C. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol 2012 Mar;52(3):568-77.
  9. Parson SJ, Russell SD, Bennett MK, Dunn JM, Gilotra NA, Rao S, Harrington C, Freitag TB, Foster MC, Halushka MK. Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. Cardiovasc Pathol 2012 Jul;21(4):317-23.

CLINICAL CHEMISTRY

  1. Marzinke MA, Jarrar P, Atkinson M, Humphrey RL, Detrick B, Sokoll LJ. Origin of a false positive urine pregnancy test in a patient with membranoproliferative glomerulonephritis type I. Clin Chim Acta 2012 Jan;413(1-2):361-3.
  2. Sokoll LJ, Chan DW, Klee GG, Roberts WL, van Schaik RH, Arockiasamy DA, Broyles DL, Carlson CM, Mizrahi IA, Pierson TB, Tam JE. Multi-center analytical performance evaluation of the Access Hybritech p2PSA immunoassay. Clin Chim Acta 2012 Aug 16;413(15-16):1279-83.
  3. Tian Y, Esteva FJ, Song J, Zhang H. Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry. Mol Cell Proteomics 2012 Jun;11(6):M111.011403.
  4. Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer. J Urol 2012 Oct;188(4):1131-6
  5. Yang SJ, Zhang H. Analysis by reversible reaction to hydrazide beads and mass spectrometry. Anal Chem 2012 Mar;84(5):2232-8.
  6. Yang W, McCrae MA. The molecular biology of rotaviruses X: intercellular dissemination of rotavirus NSP4 requires glycosylation and is mediated by direct cell-cell contact through cytoplasmic extrusions. Arch Virol 2012 Feb;157(2):305-14.

CYTOPATHOLOGY

  1. Ali SZ, Leteurtre E. The official nomenclature and terminologies in diagnostic cytopathology: history, evolution, applicability and future. Ann Pathol 2012 Dec;32(6):e3-7.
  2. Laiq Z, Bishop JA, Ali SZ. Liver lesions in children and adolescents: cytopathologic analysis and clinical correlates in 44 cases. Diagn Cytopathol 2012 Jul;40(7):586-91.
  3. Li QK, Gabrielson E, Zhang H. Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin Appl 2012 Jun;6(5-6):244-56.
  4. Holmes BJ, Hruban RH, Wolfgang CL, Ali SZ. Fine needle aspirate of autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis): cytomorphologic characteristics and clinical correlates. Acta Cytol 2012;56(3):228-32.
  5. Maleki Z, Erozan Y, Geddes S, Li QK. Endorectal ultrasound-guided fine needle aspiration: A useful diagnostic tool for peri-rectal and intraluminal lesions. Acta Cytol 2012 Dec 6;57(1):9-18
  6. Olson MT, Ali SZ. Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration. Acta Cytol 2012 Jan;56(1):15-24.
  7. Olson MT, Tatsas AD, Ali SZ. Cytotechnologist-attended on-site adequacy evaluation of thyroid fine-needle aspiration: comparison with cytopathologists and correlation with the final interpretation. Am J Clin Pathol 2012 Jul;138(1):90-5.
  8. Olson MT, Wakely PE Jr, Weber K, Siddiqui MT, Ali SZ. Postradiation sarcoma: Morphological findings on fine-needle aspiration with clinical correlation. Cancer Cytopathol 2012 Oct 25;120(5):351-7.
  9. Subhawong AP, Ali SZ, Tatsas AD. Nodular lymphocyte-predominant Hodgkin lymphoma: Cytopathologic correlates on fine-needle aspiration. Cancer Cytopathol 2012 Aug;120(4):254-60.
  10. Subhawong AP, Subhawong TK, Ali SZ. Large cell transformation of mycosis fungoides on fine needle aspiration: an unusual case mimicking classical hodgkin lymphoma. Acta Cytol 2012 May;56(3):321-4.
  11. Syed R, Bishop JA, Ali SZ. Sacral and presacral lesions: Cytopathologic analysis and clinical correlates. Diagn Cytopathol 2012 Jan;40(1):7-13.
  12. Tatsas AD, Owens CL, Siddiqui MT, Hruban RH, Ali SZ. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol 2012 Aug;120(4):261-8.
  13. Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP. Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 2012 Aug;138(2):223-9.
  14. Whitworth SA, Subhawong AP, Rosenthal DL, Ali SZ. Clear cell adenocarcinoma of the lower urinary tract: Cytopathologic characteristics and differential diagnoses. Cancer Cytopathol 2012 Oct 25;120(5):308-12.
  15. Zheng G, Schmieg J, Guan H, Ali SZ. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings. Acta Cytol 2012 Feb;56:204-8.

GI / LIVER PATHOLOGY

  1. Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol 2012 Jul;36(7):1066-73.
  2. Bai H, Gayyed MF, Lam-Himlin DM, Klein AP, Nayar SK, Xu Y, Khan M, Argani P, Pan D, Anders RA. Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol 2012 Sep;43(9):1376-85.
  3. Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S, Pan D, Anders RA. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 2012 Sep;56(3):1097-107
  4. Brosnan JA, Iacobuzio-Donahue CA. A new branch on the tree: next-generation sequencing in the study of cancer evolution. Semin Cell Dev Biol 2012 Apr;23(2):237-42.
  5. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012 Apr;142(4):796-804.
  6. Chen G, Olson MT, O'Neill AO, Norris A, Beierl K, Harada S, Debeljak M, Rivera-Roman K, Finley S, Stafford A, Gocke CD, Lin MT, Eshleman JR. A virtual pyrogram generator to resolve complex pyrosequencing results. J Mol Diagn 2012 Mar;14:149-59.
  7. Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, Rudin CM, Maitra A. A polymeric nanoparticle encapsulated small-molecule inhibitor of hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to smoothened antagonists. Mol Cancer Ther 2012 Jan;11(1):165-73.
  8. Crane CH, Iacobuzio-Donahue CA. Keys to personalized care in pancreatic oncology. J Clin Oncol 2012 Nov 20;30(33):4049-950.
  9. Cui Y, Brosnan JA, Blackford AL, Sur S, Hruban RH, Kinzler KW, Vogelstein B, Maitra A, Diaz LA Jr, Iacobuzio-Donahue CA, Eshleman JR. Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Clin Cancer Res 2012 Dec 1;18(23):6519-30
  10. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol 2012 Sep;138(3):356-66.
  11. Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong SM, Goggins MG, De Jesus-Acosta A, Laheru D, Maitra A. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Clin Cancer Res 2012 Jan 1;18(1):280-9.
  12. Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012 Feb;18(3):700-12.
  13. Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto MI, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2012 Aug 15;18(16):4303-12.
  14. Iacobuzio-Donahue CA. Personalized medicine in pancreatic cancer: prognosis and potential implications for therapy. J Gastrointest Surg 2012 Sep;16(9):1651-2.
  15. Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CE, Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res 2012 Aug 15;18(16):4257-65.
  16. Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins M. Presence of somatic mutations in most early ÔÇôstage pancreatic intraepithelial neoplasia. Gastroenterol 2012 Apr;142(4):730-3.
  17. Le A, Lane NA, Hamaker M, Bose S, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos R, Lorkiewicz P, Higashi RM, Fan WMT, Dang CV. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in human B lymphocytes. Cell Metab. 2012 Jan 4;15(1):110-21.
  18. Le A, Rajeshkumar NV, Maitra A, Dang CV. Conceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res 2012 Aug;18(16):4285-90.
  19. Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol 2012 Dec;25(12):1594-8.
  20. Maitra A, Leach SD. Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia. Cancer Cell 2012 Dec;22(6):701-3.
  21. Matsukuma KE, Montgomery EA. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall. J Clin Pathol 2012 Jul;65(7):666-8
  22. Matthaei H, Norris-Kirby A, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins M, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012 Feb;255(2):326-33.
  23. Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford) 2012 Oct;14(10):677-83.
  24. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012 Sep 1;18(17):4713-24.
  25. McDonald OG, Maitra A, Hruban RH. Human correlates of provocative questions in pancreatic pathology. Adv Anat Pathol 2012 Nov;19(6):351-62.
  26. Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, NV RK.. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol Cancer Ther. 2012 Sep;11(9):1999-2009
  27. Montgomery E, Voltaggio L, Canto MI. Much ado about very little (lamina propria)? Gastrointest Endosc 2012 Jan;75(1):19-22.
  28. Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D, Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra A. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget 2012 Jul;3(6):640-50
  29. Salaria SN, Streppel MM, Lee LA, Iacobuzio-Donahue CA, Montgomery EA. Sessile serrated adenomas: high-risk lesions? Hum Pathol 2012 Nov;43(11):1808-14.
  30. Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. Am J Surg Pathol. 2012 May;36(5):710-5.
  31. Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol 2012 Jul;36(7):1030-5.
  32. Streppel MM, Vincent A, Mukherjee R, Campbell NR, Chen SH, Konstantopoulos K, Goggins MG, Van Seuningen I, Maitra A, Montgomery EA. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum Pathol 2012 Oct;43(10):1755-63.
  33. Wood LD, Hruban RH. Pathology and molecular genetics of pancreatic neoplasms. Cancer J 2012 Nov;18 (6):492-501.
  34. Xu Y, Chenna V, Hu C, Sun HX, Khan M, Bai H, Yang XR, Zhu QF, Sun YF, Maitra A, Fan J, Anders RA. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (nanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 2012 Mar 1;18(5):1291-302.
  35. Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CA. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012 Feb;36(2):173-84.
  36. Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA, Herman JM, Hruban RH, Klein AP, Jones S, Velculescu V, Wolfgang CL, Iacobuzio-Donahue CA. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res 2012 Nov;18(22):6339-47.
  37. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012 Feb;18(4):981-92.
  38. Yu J, Walter K, Omura N, Hong S-M, Young A, Li A, Vincent A, Goggins M. Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2-deoxycytidine. PLoS One 2012 Sept;7(9):e43456.

GENITOURINARY PATHOLOGY

  1. Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol 2012 Feb;43(2):254-60.
  2. Al Hussain T, Nagar MS, Epstein JI. Gleason pattern 5 is frequently underdiagnosed on prostate needle core biopsy. Urology 2012 Jan;79:178-81.
  3. Amin A, Epstein JI. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases. Hum Pathol 2012;43:2124-8
  4. Bagnasco SM. Protein kinase C comes to the rescue of aquaporin 2. Am J Physiol Renal Physiol 2012 Jul;303(1):F35-6.
  5. Bagnasco SM, Subramanian AK, Desai NM. Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft. Transpl Infect Dis 2012 Jun;14(3):288-91.
  6. Berman DM, Bosenberg MW, Orwant RL, Thurberg BL, Draetta GF, Fletcher CD, Loda M. Investigative pathology: leading the post-genomic revolution. Lab Invest 2012 Jan;92(1):4-8.
  7. Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol 2012 Mar;43:313-24.
  8. Brimo F, Epstein JI. Selected common diagnostic problems in urological pathology: perspectives from a large genitourinary consult service. Arch Pathol Lab Med 2012 Apr;136:360-71.
  9. Carter HB, Partin AW, Walsh PC, Trock BJ, Nelson WG, Coffet DS, Singer EA, Epstein JI. Gleason score 6 adenocarcinoma: Should it be labeled as cancer. JCO 2012 Dec;30:4294-6.
  10. Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012 Oct;36(10):1472-6.
  11. Chaux A, Brimo F, Gonzalez-Roibon N, Shah S, Schultz L, Rizk JM, Argani P, Hicks J, Netto GJ. Immunohistochemical evidence of dysregulation of the Mammalian target of rapamycin pathway in primary and metastatic pheochromocytomas. Urology 2012 Sep;80(3):736.e7-736.e12.
  12. Chaux A, Cohen JS, Schultz L, Albadine R, Jadallah S, Murphy KM, Sharma R, Schoenberg MP, Netto GJ. High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues. Hum Pathol 2012 Oct;43(10):1590-5.
  13. Chaux A, Fajardo DA, Gonzalez-Roibon N, Partin AW, Eisenberger M, Deweese TL, Netto GJ. High-grade prostatic adenocarcinoma present in a single biopsy core as associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy. Urology 2012 Apr;79(4):863-8.
  14. Chaux A, Karram S, Miller JS, Fajardo DA, Lee TK, Miyamoto H, Netto GJ. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Hum Pathol 2012 Jan;43(1):115-20.
  15. Chaux A, Peskoe SB, Gonzalez-Roibon N, Schultz L, Albadine R, Hicks J, De Marzo AM, Platz EA, Netto GJ. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod Pathol 2012 Nov;25(11):1543-9.
  16. Chaux A, Schultz L, Albadine R, Hicks J, Kim JJ, Allaf ME, Carducci MA, Rodriguez R, Hammers HJ, Argani P, Reuter VE, Netto GJ. Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas. Hum Pathol 2012 Dec;43(12):2129-37.
  17. Epstein JI. The diagnosis of limited adenocarcinoma of the prostate. Histopathol 2012 Jan;60:28-40.
  18. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using The modified Gleason grading system and factoring in tertiary grades. Eur Urol 2012 May;61:1019-24.
  19. Epstein JI, Leclercq NR. Diagnostic issues of prostate biopsies: PIN-like ductal adenocarcinoma. Ann Pathol 2012 Apr;32:132-6.
  20. Han JS, Toll AD, Carter B, Landis P, Lee S, Epstein JI. Low prostate specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant cancer at radical prostatectomy. Urology 2012 Oct;80(4):883-8.
  21. Kryvenko ON, Epstein JI. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens. Am J Surg Pathol 2012 Dec;36:1865-73.
  22. Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S, Rybicki BA. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 2012 Jul;25(7):1023-32.
  23. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK; for the ALT Starr Cancer Consortium. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 2012 Jul;8(7):e1002772
  24. Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol 2012 Nov;43(11):2033-40.
  25. Netto GJ. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 2012 Jan;9(1):41-51.
  26. Netto GJ, Cheng L. Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med 2012 Apr;136(4):372-90.
  27. Pisitkun T, Gandolfo MT, Knepper M, Bagnasco SM. Application of system biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation. Proteomics Clin Appl 2012 June;6(5-6):268-78.
  28. Ross HM, Kryvenko O, Cowan J, Simko JP, Wheeler TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score (GS) <6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 2012 Sep;36(9):1346-52.
  29. Sfanos KS, Aloia AL, De Marzo AM, Rein A. XMRV and prostate cancer a 'final' perspective. Nat Rev Urol 2012 Feb;9:111-8.
  30. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology 2012 Jan;60(1):199-215.
  31. Toll A, Epstein JI. Invasive low grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 case. Am J Surg Pathol 2012 Jul;36:1081-6.
  32. Toubaji A, Sutcliffe S, Chaux A, Lecksell K, Hicks J, De Marzo AM, Platz EA, Netto GJ. Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases. Hum Pathol 2012 Nov;43(11):1852-65.
  33. Van Neste L, Bigley J, Toll A, Otto G,Clark J, Delree P, Van Criekinge W, Epstein JI. A tissue biopsy based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol 2012 June;12:16.

GYNECOLOGIC PATHOLOGY

  1. Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, Shih IM. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer 2012 Oct;22(8):1310-5.
  2. Chang CL, Hsu YT, Wu CC, Yang YC, Wang C, Wu TC, Hung CF. Immune mechanism of the antitumor effects generated by bortezomib. J Immunol 2012 Sep 15;189(6):3209-20.
  3. Guan B, Gao M, Wu CH, Wang TL, Shih IeM. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. Neoplasia 2012 Oct;14(10):986-93.
  4. Hung C-F, Chiang AJ, Tsai H-H, Pomper MG, Kang TH, Roden RR, Wu T-C. Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene. PLoS ONE 2012 July;7(7):e40983.
  5. Jones S, Wang TL, Kurman RJ, Nakayama K, Velculescu VE, Vogelstein B, Kinzler KW, Papadopoulos N, Shih IeM. Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol. 2012 Feb;226(3):413-20.
  6. Kang TH, Mao C-P, He L, Tsai YC, Liu K, La V, Wu T-C, Hung C-F. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects. PLoS ONE 2012 Apr;7(4):e35141
  7. Kshirsagar M, Jiang W, Shih IeM. DNA damage response is prominent in ovarian hgh-grade serous carcinomas, especially those with Rsf-1 (HBXAP) overexpression. J Oncol 2012;2012:621685.
  8. Kuhn E, Kurman RJ, Sehdev AS, Shih IeM. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 2012 Sep;31(5):416-22.
  9. Kuhn E, Kurman RJ, Soslow RA, Han G, Sehdev AS, Morin PJ, Wang TL, Shih IeM. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Am J Surg Pathol 2012 Dec;36(12):1826-34.
  10. Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih IeM. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. J Pathol 2012 Feb;226(3):421-6.
  11. Kuhn E, Wu RC, Guan B, Wu G, Zhang J, Wang Y, Song L, Yuan X, Wei L, Roden RB, Kuo KT, Nakayama K, Clarke B, Shaw P, Olvera N, Kurman RJ, Levine DA, Wang TL, Shih IeM. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst 2012 Oct 3;104(19):1503-13.
  12. Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, Micetich K, Libby AL, Ronnett BM. Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol 2012 Jan;31(1):73-9.
  13. Seidman JD, Yemelyanova A, Cosin JA, Smith A, Kurman RJ. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review. Int J Gynecol Cancer 2012 Mar;22(3):367-71.
  14. Sheu JJ, Guan B, Tsai FJ, Hsiao EY, Chen CM, Seruca R, Wang TL, Shih IeM. Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells. Am J Pathol 2012 Mar;180(3):1179-88.
  15. Vang R, Gupta G, Wu LS, Yemelyanova AV, Kurman RJ, Murphy KM, DeScipio C, Ronnett BM. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol 2012 Mar;36:443-53.
  16. Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, Li R, Ronnett BM, Seidman JD, Yemelyanova A, Shih IM, Shaw PA, Soslow RA, Kurman RJ. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 2012 May;31:243-53.
  17. Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 2012 Jul;31(4):297-303.
  18. Yap KL, Fraley SI, Thiaville MM, Jinawath N, Nakayama K, Wang J, Wang TL, Wirtz D, Shih IeM. NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. Cancer Res 2012 Aug 15;72(16):4085-96.

HEMATOLOGIC PATHOLOGY

  1. Burns KH, Boeke JD. Human transposon tectonics. Cell 2012 May 11;149(4):740-52
  2. Duffield AS, Aoki J, Levis M, Cowan K, Gocke CD, Burns KH, Borowitz MJ, Vuica-Ross M. Clinical and pathologic features of secondary acute promyelocytic leukemia. Am J Clin Pathol 2012 Mar;137(3):395-402.
  3. McCall CM, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Flow cytometric findings in hemophagocytic lymphohysitiocytosis. Am J Clin Pathol 2012 May;137:786-94.
  4. Wu JM, Vonderheid E, Gocke CD, Moresi JM, Liegeois N, Borowitz MJ. Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas. J Cutan Pathol 2012 Oct;39(10):918-28.

IMMUNOLOGY

  1. Allen JG, Lee MT, Weiss ES, Arnaoutakis GJ, Shah AS, Detrick B. Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg 2012 Jun;93(6):1843-9.
  2. Amukele TK, Michael K, Hanes M, Miller RE, Jackson JB. External quality assurance performance of clinical research laboratories in sub-saharan Africa. Am J Clin Pathol 2012 Nov;138(5):720-3.
  3. Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou SC, Ladenson PW. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology 2012 Sep;153(9):4580-7.
  4. Chen P, Baldeviano G, Ligons D, Talor M, Barin J, Rose NR, Cihakova D. Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4+ T cells. Clin Exp Immunol 2012 Aug;169(2):79-88.
  5. Barbesino G, Sluss PM, Caturegli P. Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis. J Clin Endocrinol Metab 2012 Feb;97(2):345-50.
  6. Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Quader F, Chen P, Zheng D, Caturegli P, Rose NR, Cihakova D. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 2012 Mar;42(3):726-36.
  7. Barin JG, Rose NR, Cihakova D. Macrophage diversity in cardiac inflammation: a review. Immunobiology 2012 May;217(5):468-75.
  8. Bishop JA, Sharma R, Netto G, Illei PB. Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma-Reply. Human Pathol 2012 July;43(7):1154.
  9. Cimino-Mathews A, Sharma R, Illei PB. Detection of human papillomavirus in small cell carcinomas of the anus and rectum. Am J Surg Pathol 2012 Jul;36(7):1087-92.
  10. Guaraldi F, Landek-Salgado MA, Hutfless S, Samoni F, Talor MV, Matos PG, Salvatori R, Rose NR, Caturegli P. Pituitary antibodies in women with Hashimoto's thyroiditis: prevalence in diagnostic and prediagnostic sera. Thyroid 2012 May;22(5):509-15.
  11. Hamad AR, Arcara K, Uddin S, Donner T. The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Front Immunol 2012;3:196.
  12. Iwama S, De Remigis A, Bishop JA, Kimura HJ, Caturegli P. Hurthle cells predict hypothyroidism in interferon-transgenic mice of different genetic backgrounds. Endocrinology 2012 Aug;153(8):4059-66.
  13. Landek-Salgado MA, Leporati P, Lupi I, Geis A, Caturegli P. Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis. Pituitary 2012 Sep;15(3):412-9.
  14. Landek-Salgado MA, Rose NR, Caturegli P. Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1. J Autoimmun. 2012 May;38(2-3):J88-96.
  15. Maters AW, Wright CV, Lee MT, Schwichtenberg G, Detrick B. Detection of type-specific antibodies to HSV-1 and HSV-2: comparative analysis of a chemiluminescence immunoassay with a conventional ELISA. Diagn Microbiol Infect Dis 2012 Jul;73(3):273-4.
  16. Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C, Humble MC, Rose NR. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012 Dec;39(4):253-8.
  17. Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci (Schol Ed) 2012 Jun;4:1325-32.
  18. Webb TJ, Li X, Giuntoli RL 2nd, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, Oelke M, Schneck JP. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res 2012 Aug 1;72(15):3744-52.

INFORMATICS

  1. Cornish TC, Swapp RE, Kaplan KJ. Whole-slide imaging: routine pathologic diagnosis. Adv Anat Pathol 2012 May;19(3):152-9.
  2. Kim B, Barker JB, Hruban RH, Sandone C, Cornish TC. The Johns Hopkins Atlas of Pancreatic Pathology: developing an interactive Atlas and teaching algorithm for the Apple iPad. J Biocommun 2012;38(1):4-10.
  3. Lai H, Detrick B, Fishman EK, Gerstenblith G, Brinker JA, Hollis BW, Bartlett J, Cofrancesco J Jr, Tong W, Tai H, Chen S, Bhatia S, Lai S. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med 2012 Jun;60(5):801-7.
  4. Lai H, Fishman EK, Gerstenblith G, Brinker JA, Tong W, Bhatia S, Detrick B, Lai S. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol 2012 Jul 12;158(2):211-6.
  5. Lai H, Gerstenblith G, Fishman EK, Brinker J, Kickler T, Tong W, Bhatia S, Hong T, Chen S, Li J, Detrick B, Lai S. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis 2012 Jun;54(12):1747-55.

MEDICAL MICROBIOLOGY

  1. Bishop JA, Nelson AM, Merz WG, Askin FB, Riedel S. Evaluation of the detection of melanin by the Fontana-Masson silver stain in tissue with a wide range of organisms including Cryptococcus. Hum Pathol 2012 Jun;43(6):898-903.
  2. Dumler JS. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol. 2012 Feb;64(1):13-20.
  3. Forman MS, Advani S, Newman C, Gaydos CA, Milstone AM, Valsamakis A. Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort. J Clin Virol 2012 Oct;55(2):168-72.
  4. Frevert U, Movila A, Nikolskaia OV, Raper J, Mackey ZB, Abdulla M, McKerrow J, Grab DJ. Early invasion of brain parenchyma by African trypanosomes. PLoS One 2012 Aug;7(8):e43913.
  5. Kwiatkowski NP, Babiker WM, Merz WG, Carroll KC, Zhang SX. Evaluation of nucleic acid sequencing of the D1/D2 region of the large-subunit of the 28S rDNA and the Internal Transcribed Spacer region using SmartGeneTM IDN software for identification of filamentous fungi in a Clinical Laboratory. J Mol Diagn 2012 Jul;14(4):393-401.
  6. Mahmud A, Lee R, Munfus-McGray D, Kwiatkowski N, Subramanian A, Neofytos D, Carroll K, Zhang SX. Actinomucor elegans as an emerging cause of mucormycosis: case report and review. J Clin Microbiol 2012 March;50(3):1092-5.
  7. Meriden Z, Marr K, Lederman HM, Illei PB, Villa K, Riedel S, Carroll KC, Zhang SX. Ochrochonis gallopava infection in a patient with chronic granulomatous disease. Med Mycol 2012 Nov;50(8):890-6.
  8. Milstone AM, Perl TM, Valsamakis A. Epidemiology of respiratory viruses in children admitted to an infant/toddler unit. Am J Infect Control. 2012 Jun;40(5):462-4.
  9. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, Broadwater A, stbye T, de Silva A, Woods CW. Unsuspected dengue and acute febrile illness in rural and semi-urban Southern Sri Lanka. Emerg Infect Dis 2012 February;18(2):256-63.
  10. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, Flom JE, Østbye T, Woods CW, Dumler JS. Unsuspected rickettsioses among patients with acute febrile illness, Sri Lanka, 2007. Emerg Infect Dis 2012 May;18(5):825-9.
  11. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012 Jul;73(3):221-7.
  12. Riedel S, Dionne K, Ellis C, Duffield A, Carroll KC, Parrish NM. Mycobacterium szulgai: an unusual cause of disseminated mycobacterial infections. Infection 2012 Aug;40(4):463-8
  13. Seah C, Richardson SE, Tsui G, Yu B, Thornback J, McTaggart L, Boggild A, Wengenack NL, Zhang SX. Comparison of the FXGTM: RESP (Asp +) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. Medical Mycology 2012 Apr;50(3):324-7.
  14. Sydnor ER, Greer A, Budd AP, Pehar M, Munshaw S, Neofytos D, Perl TM, Valsamakis A. An outbreak of human parainfluenza virus 3 infection in an outpatient hematopoietic stem cell transplantation clinic. Am J Infect Control 2012 Sep;40(7):601-5.
  15. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol 2012 Oct;50(10):3301-8
  16. Zhang SX. Non-culture based methods in diagnostic mycology. Clin Microbiol Newsletter 2012 July; 34(13):101-5

MOLECULAR PATHOLOGY

  1. Argani P, Yonescu R, Morsberger L, Morris K, Netto GJ, Smith N, Gonzalez N, Illei PB, Ladanyi M, Griffin CA. Molecular Confirmation of the t(6;11)(p21;q12) Renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol 2012 Oct;36(10):1516-26.
  2. Belchis DA, Shekitka K, Gocke CD. A unique, histopathologic lesion in a subset of patients with spontaneous pneumothorax. Arch Pathol Lab Med. 2012 Dec;136(12):1522-7.
  3. Descipio C, Conlin L, Rosenfeld J, Tepperberg J, Pasion R, Patel A, McDonald MT, Aradhya S, Ho D, Goldstein J, McGuire M, Mulchandani S, Medne L, Rupps R, Serrano AH, Thorland EC, Tsai AC, Hilhorst-Hofstee Y, Ruivenkamp CA, Van Esch H, Addor MC, Martinet D, Mason TB, Clark D, Spinner NB, Krantz ID. Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization. Am J Med Genet A. 2012 Sep;158A(9):2152-61.
  4. Gocke CD, Mason J, Brusca L, Laosinchai-Wolf W, Higgs C, Newell H, Masters A, Friar L, Karp J, Griffiths M, Wei Q, Labourier E. Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation study. Blood Cancer J 2012 July;2:e78-e86.
  5. Jinawath N, Zambrano R, Wohler E, Palmquist MK, Hoover-Fong J, Hamosh A, Batista DA. Mosaic trisomy 13: understanding origin using SNP array. J Med Genet 2011 May;48(5):323-6.

NEUROPATHOLOGY

  1. Chiang PM, Fortna RR, Price DL, Li T, Wong PC. Specific domains in anterior pharynx-defective 1 determine its intramembrane interactions with nicastrin and presenilin. Neurobiol Aging. 2012 Feb;33(2):277-85.
  2. Codispoti K-E, Beason-Held LL, Kraut MA, O'Brien RJ, Rudow G, Pletnikova O, Crain B, Troncoso JC, Susan Resnick SM. Longitudinal brain activity changes in asymptomatic Alzheimer disease. Brain and Behavior 2012;2(3):221ÔÇô30.
  3. Eberhart C. Three down and one to go: modeling medulloblastoma subgroups. Cancer Cell 2012;21:137-8. (review)
  4. Gertz B, Wong M, Martin LJ. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol 2012 Feb;71(2):162-77.
  5. Guo Z, Rudow G, Pletnikova O, Codispoti KE, Orr BA, Crain BJ, Duan W, Margolis RL, Rosenblatt A, Ross CA, Troncoso JC. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Mov Disord 2012 Sep 15;27(11):1379-86.
  6. Lim KJ, Rajan K, Eberhart CG. Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and notch signaling. Anticancer Res 2012 Jul;32(7):2689-96.
  7. Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 2012 Jan;71(1):66-72.
  8. Orr BA, Eberhart CG. Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. Am J Pathol 2012 May;180(5):1768-71.
  9. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival inmalignant glioma. PLoS One 2012 Jul 19;7(7):e41036.
  10. Raabe EH, Eberhart CG. Methylome alterations "mark" new therapeutic opportunities in glioblastoma. Cancer Cell 2012 Oct 16;22(4):417-8.
  11. Rodriguez FJ. Peripheral nerve sheath tumors: the elegant chapter in surgical neuropathology. Acta Neuropathol 2012 Mar;123(3):293-4.
  12. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 2012 Mar;123(3):295-319.
  13. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin's dark side: Possible role in tumor progression. Biochim Biophys Acta 2012 Aug;1826(1):23-31.
  14. Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG. Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 2012 Jan;3(1):98-106.
  15. Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012 Nov;124(5):627-41.
  16. Rodriguez FJ, Stratakis CA, Evans DG. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol 2012 Mar;123(3):349-67.
  17. Savonenko AV, Melnikova T, Hiatt A, Li T, Worley PF, Troncoso JC, Wong PC, Price DL. Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology 2012 Jan;37(1):261-77.
  18. Tabbarah AZ, Carlson AW, Oviedo A, Ketterling RP, Rodriguez FJ. Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation. Clin Neuropathol 2012 May-Jun;31(3):142-5.
  19. Tsao W, Jeong YH, Lin S, Ling J, Price DL, Chiang PM, Wong PC. Rodent models of TDP-43: recent advances. Brain Res. 2012 Jun 26;1462:26-39.

OPHTHALMIC PATHOLOGY

  1. Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG. Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res 2012 Feb;18(3):654-65.
  2. Rodriguez FJ, Ligon AH, Horkayne-Szakaly I, Rushing EJ, Ligon KL, Vena N, Garcia DI, Cameron JD, Eberhart CG. BRAF Duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper. J Neuropathol Exp Neurol 2012 Sep;71(9):789-94.

SURGICAL PATHOLOGY

  1. Amin A, Epstein JI. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases. Hum Pathol 2012;43:2124-8
  2. Al Hussain T, Nagar MS, Epstein JI. Gleason pattern 5 is frequently underdiagnosed on prostate needle core biopsy. Urology 2012 Jan;79:178-81.
  3. Argani P, Yonescu R, Morsberger L, Morris K, Netto GJ, Smith N, Gonzalez N, Illei PB, Ladanyi M, Griffin CA. Molecular Confirmation of the t(6;11)(p21;q12) Renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol 2012 Oct;36(10):1516-26.
  4. Begum S. Molecular changes in smoking-related lung cancer. Expert Rev Mol Diagn. 2012 Jan;12(1):93-106.
  5. Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol 2012 Dec;36(12):1874-82.
  6. Bishop JA, Maleki Z, Valsamakis A, Ogawa T, Chang X, Pai SI, Westra WH. Application of the Hybrid Capture 2 assay to squamous cell carcinomas of the head and neck: A convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2012 Feb 25;120(1):18-25.
  7. Bishop JA, Ogawa T, Chang X, Illei PB, Gabrielson E, Pai SI, Westra WH. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012 Jan;36(1):142-8.
  8. Bishop JA, Sharma R, Netto G, Illei PB. Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma-Reply. Human Pathol 2012 July;43(7):1154
  9. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (Δp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012 Mar;25(3):405-15.
  10. Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012 Aug;36(8):1216-21.
  11. Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid 2012 Jul;22(7):690-4
  12. Brimo F, Epstein JI. Selected common diagnostic problems in urological pathology: Perspectives from a large genitourinary consult service. Arch Pathol Lab Med 2012 Apr;136:360-71.
  13. Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol 2012 Mar;43:313-24.
  14. Carter HB, Partin AW, Walsh PC, Trock BJ, Nelson WG, Coffet DS, Singer EA, Epstein JI. Gleason score 6 adenocarcinoma: Should it be labeled as cancer. JCO 2012Dec;30:4294-6.
  15. Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012 Oct;36(10):1472-6.
  16. Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA. Small cell carcinoma ex-pleomorphic adenoma of the parotid gland. Head Neck Pathol 2012 Dec;6(4):502-6.
  17. Cimino-Mathews A, Sharma R, Illei PB. Detection of human papillomavirus in small cell carcinomas of the anus and rectum. Am J Surg Pathol 2012 Jul;36(7):1087-92.
  18. El-Naggar AK, Westra WH. P16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretive relevance and consistency. Head Neck 2012 Apr;34(4):459-61.
  19. Epstein JI. The diagnosis of limited adenocarcinoma of the prostate. Histopathol 2012 Jan;60:28-40.
  20. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using The modified Gleason grading system and factoring in tertiary grades. Eur Urol 2012 May;61:1019-24.
  21. Epstein JI, Leclercq NR. Diagnostic issues of prostate biopsies: PIN-like ductal adenocarcinoma. Ann Pathol 2012 Apr;32:132-6.
  22. Han JS, Toll AD, Carter B, Landis P, Lee S, Epstein JI. Low prostate specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant cancer at radical prostatectomy. Urology 2012 Oct;80(4):883-8.
  23. Kryvenko ON, Epstein JI. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens. Am J Surg Pathol 2012 Dec;36:1865-73.
  24. Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 2012 May;36(5):783-4.
  25. Ross HM, Kryvenko O, Cowan J, Simko JP, Wheeler TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score (GS) <6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 2012 Sep;36(9):1346-52.
  26. Ross H, Martignoni G, Argani P. Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 2012 Apr;136(4):391-9.
  27. Singhi AD, Califano J, Westra WH. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2012 Feb;34(2):213-8.
  28. Singhi AD, Cimino-Mathews A, Jenkins RB, Lan F, Fink SR, Nassar H, Vang R, Fetting JH, Hicks J, Sukumar S, De Marzo AM, Argani P. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol 2012 Mar;25(3):378-87.
  29. Toll A, Epstein JI. Invasive low grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases. Am J Surg Pathol 2012 Jul;36:1081-6.
  30. Van Neste L, Bigley J, Toll A, Otto G,Clark J, Delree P, Van Criekinge W, Epstein JI. A tissue biopsy based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol 2012 June;12:16.
  31. Wakely PE Jr, Ali SZ, Bishop JA. The cytopathology of malignant peripheral nerve sheath tumor : a report of 55 fine-needle aspiration cases. Cancer Cytopathol 2012 Oct 25;120(5):334-41.

TRANSFUSION MEDICINE

  1. Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG. Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single dose nevirapine. J Acquir Immune Defic Syndr 2012 Aug;60(5):483-8.
  2. Amukele TK, Michael K, Hanes M, Miller RE, Jackson JB. External quality assurance performance of clinical research laboratories in sub-saharan Africa. Am J Clin Pathol 2012 Nov;138(5):720-3.
  3. Brunker, PAR. Immunology IV: clinical applications in health and disease. Transfusion 2012 Aug;52(8):1836.
  4. Cousins MM, Swan D, Margaret CA, Hoover DR, Eshleman SH. Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. 12/2012. PLoS One 7(12):e51359.
  5. Eipl K, Nakabiito C, Bwogi K, Motevalli M, Roots A, Blagg L, Jackson JB. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.Immunohematol 2012 Dec;28(4):115-7.
  6. Guo N, Wang J, Ness P, Yao F, Bi X, Li J, Yun Z, Guo X, Huang Y, Dong X, Tiemuer MH, He W, Ma H, Huang M, Liu J, Wright DJ, Nelson K, Shan H; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Component. First-time donors responding to a national disaster may be an untapped resource for the blood centre. Vox Sang 2012 May;102(4):338-44.
  7. Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, Mei H, Li J, He W, Lu Y, Ma H, Wen X, Huang M, Liu J, Wright DJ, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Demographics of apheresis platelet donors in five blood centers in China. Transfusion 2012 Mar:52(3):560-6.
  8. Jackson JB, Onyango-Makumbi C. Reply to "Were the interests of the vulnerable truly served? The predictable failure of HIV immune globulin". JAIDS 2012 Sept;61(1):e10-12.
  9. James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel J, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. Use of a high resolution melting (HRM) assay to analyze HIV diversity in HIV-infected Ugandan children. Ped Infect Dis 2012 Nov;31(11):e222-e228.
  10. Jerrard GA, Liu J, Case R, Motevalli M, Bolton SG, King KE, Beigel J, Jackson JB. Implications of weight and body mass index for plasma donation and health. ISRN Hematology;2012(2012),Article ID 937585, 5 pages.
  11. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Costs and effectiveness of neonatal male circumcision. Arch Pediatr Adolesc Med 2012;166:910-8.
  12. Karafin MS, Blagg L, Tobian AAR, King KE, Ness PM, Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to incompatible platelet transfusions. Transfusion 2012 Oct;52(10):2087-93
  13. Karafin M, Fuller A, Savage WJ, King KE, Ness PM, Tobian AAR. The impact of apheresis platelet manipulation on corrected count increment. Transfusion 2012 June;52:1221-7.
  14. Karafin M, Shirey RS, Ness PM, King KE. Antigen matched red cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital. Immunohematology 2012;28:3-6.
  15. Karafin MS, Shirey RS, Ness PM, King KE, Keefer J. A case study of a child with chronic hemolytic anemia due to a Donath-Landsteiner-positive, IgM anti-I autoantibody. Pediatr Blood Cancer 2012 Nov;59(5):953-5.
  16. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 2012 Aug;28(8):816-22.
  17. Pagano MB, Hobbs W, Linenberger M, Delaney M. Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature. J Clin Apher 2012 Dec;27(6):336-41.
  18. Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH. Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. AIDS Res Hum Retroviruses 2012 Dec;28(12):1739-44.
  19. Savage WJ, Savage JH, Tobian AAR, Thoburn C, Hamilton RG, Schroeder JT, Ness PM. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012 Mar;52(3):575-81.
  20. Tobian AAR, Gray RH. Benefits of male circumcision - Reply. JAMA 2012 Feb;307(5):457. (Letter).
  21. Tobian AAR, Kigozi G, Gravitt PE, Xiao C, Serwadda D, Eaton K, Kong X, Wawer MJ, Nalugoda F, Quinn TC, Gray RH. Risk factors for human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012 Jul 31;26(12):1555-65
  22. Tobian AAR, Kigozi G, Redd AD, Serwadda D, Kong X, Oliver AE, Nalugoda F, Quinn TC, Gray RH, Wawer MJ. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis 2012 Feb;205:486-90.
  23. Zeng P, Wang J, Huang Y, Guo X, Li J, Wen G, Yang T, Yun Z, He M, Liu Y, Yuan Y, Schulmann J, Glynn S, Ness P, Jackson JB, Shan H; for the Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. Transfusion 2012 May;52(5):1041-9.